Rein Therapeutics RNTX
NASDAQ RNTX
$0.80 -0.05 (-5.88%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Return on Assets [ROA] (2017 - 2026)

Updated

Rein Therapeutics (RNTX) reported Return on Assets [ROA] of -107.21% for Q2 2026, down 0.62 percentage points from -106.59% a year earlier but up 92.02 percentage points from the prior quarter.

Analysis

Rein Therapeutics (RNTX) Return on Assets [ROA] (2017 - 2026) Analysis & Trends

For FY2025, Rein Therapeutics posted Return on Assets [ROA] of -115.62%, down 40.04 percentage points from FY2024.

  • Return on Assets [ROA] has a five-year change of -19.88 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -75.59% in FY2024 (-50.16 pp), -25.43% in FY2023 (+53.02 pp), -78.44% in FY2022 (+3.64 pp) and -82.09% in FY2021 (+13.66 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -199.23% in Q1 2026 and a high of -18.00% in Q1 2024.
  • Year over year, Return on Assets [ROA] has now declined in each of the last seven quarters, with an average year-over-year change of -46.73 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q1 2024 (a gain of 105.77 percentage points); the low point was Q1 2026 (a drop of 93.21 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -199.23% (Q1 2026), -130.05% (Q4 2025) and -109.31% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Rein Therapeutics 53.67 Mn 53.67 Mn - -107.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -107.21%
Mar 31, 2026 -199.23%
Dec 31, 2025 -130.05%
Sep 30, 2025 -109.31%
Jun 30, 2025 -106.59%
Mar 31, 2025 -106.02%
Dec 31, 2024 -78.26%
Sep 30, 2024 -27.72%
Jun 30, 2024 -24.47%
Mar 31, 2024 -18.00%
Dec 31, 2023 -27.39%
Sep 30, 2023 -102.11%
Jun 30, 2023 -116.78%
Mar 31, 2023 -123.77%
Dec 31, 2022 -112.30%
Sep 30, 2022 -97.57%
Jun 30, 2022 -81.24%
Mar 31, 2022 -63.19%
Dec 31, 2021 -51.54%
Sep 30, 2021 -41.60%
API Access

Rein Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RNTX&period=max&api_key=YOUR_API_KEY